1. Home
  2. ATXG vs AEMD Comparison

ATXG vs AEMD Comparison

Compare ATXG & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Addentax Group Corp.

ATXG

Addentax Group Corp.

N/A

Current Price

$2.80

Market Cap

4.1M

ML Signal

N/A

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

N/A

Current Price

$5.46

Market Cap

4.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATXG
AEMD
Founded
2014
1984
Country
China
United States
Employees
N/A
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
4.3M
IPO Year
2015
2008

Fundamental Metrics

Financial Performance
Metric
ATXG
AEMD
Price
$2.80
$5.46
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
★ $13.25
AVG Volume (30 Days)
5.9K
★ 59.6K
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.53
52 Week High
$9.56
$26.90

Technical Indicators

Market Signals
Indicator
ATXG
AEMD
Relative Strength Index (RSI) 36.48 53.34
Support Level $2.50 $4.86
Resistance Level $3.88 $6.69
Average True Range (ATR) 0.20 0.34
MACD 0.01 -0.10
Stochastic Oscillator 40.76 47.06

Price Performance

Historical Comparison
ATXG
AEMD

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services and Consulting. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

Share on Social Networks: